Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sistemic is a private biotechnology and molecular diagnostics company based in Glasgow, Scotland that focuses on microRNA and other non-coding RNA analysis for cell therapy, gene therapy, bioprocessing, and drug discovery applications. Rather than developing its own therapeutic pipeline, the company commercializes analytical products and services that help customers characterize cells, monitor quality attributes, detect residual pluripotent stem cells, investigate toxicity signals, and support drug repositioning decisions. Its named offerings include SistemPSCCheck, SistemQC, SistemRNA, SistemTOX, and SistemKB. The company positions its platform as a way to generate low-cost, information-rich biomarkers and quality metrics for advanced therapy developers and biopharma partners. Sistemic appears to operate as an active, private, platform-based life science tools and services company rather than a clinical-stage drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sistemic Scotland.